Starr Michelle C, Patel Mital, Zafar Faizeen, Zhou Melissa S, Griffin Russell, Biruete Annabel, Cockovski Vedran, Gbadegesin Rasheed, Fuhrman Dana Y, Gist Katja M, Mammen Cherry, Menon Shina, Morgan Catherine, Slagle Cara L, Sutherland Scott, Zappitelli Michael, Soranno Danielle E
Division of Nephrology, Department of Pediatrics, Indiana University School of Medicine, 1044 West Walnut Street, Indianapolis, IN, 46202, USA.
Division of Child Health Service Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Pediatr Nephrol. 2025 May 9. doi: 10.1007/s00467-025-06801-6.
Acute kidney injury (AKI) occurs commonly in critically ill children. The impact of AKI on pediatric growth outcomes has been sparsely described.
To compare growth in children with a history of AKI compared to those without AKI. We hypothesized that children with AKI would have worse growth compared to those without AKI.
A convenience sample of existing prospective and retrospective cohorts of children with AKI who had already collected or were able to collect data on growth parameters before and after an episode of AKI.
There are < 5 studies in the published literature on growth in children with AKI. These investigators were contacted, and additional studies were added by contacting primary investigators of studies of childhood AKI in which data on growth parameters was able to be collected.
Children from existing cohorts evaluating AKI (exposure) during childhood. Each included cohort had previously received local IRB approval per institutional guidelines. As our study was a meta-analysis and only used cohort-level data, no IRB approval was required for this report.
Growth parameters (length and weight z-scores) before and after an episode of AKI were compared using a meta-means analysis. MOOSE guidelines were used. Data were pooled using a random-effects model. Hedges g was calculated, and Higgins I statistic was used to define variability due to between-cohort heterogeneity.
We included 3,586 children from 17 existing cohorts of AKI in various populations, including infants, children with cardiac disease, solid organ transplant and critically ill children without cardiac disease with follow-up from 12 months to 11 years after AKI. At most distant follow-up, those with AKI had lower length z-score than those without AKI (mean difference -0.37 [95%CI -0.52, -0.22, p < 0.001]) and lower weight z-score (mean difference of -0.29 [95%CI -0.43, -0.15, p < 0.001]). This difference was most striking in infants, as those with AKI had impaired growth (both length z-score and weight z-score) after AKI compared to those without AKI.
The analysis included only a convenience sample of observational cohorts of children, study selection could have been biased, and we did not evaluate the relationship between decreased kidney function (e.g., chronic kidney disease) after AKI in these cohorts and its relationship to poor growth.
This meta-analysis found that children with AKI have impaired growth after AKI. These findings were most striking in infants. We suggest focusing on growth outcomes in both clinical care and research investigating the impacts of AKI.
NA.
急性肾损伤(AKI)在危重症儿童中很常见。AKI对儿童生长结局的影响鲜有描述。
比较有AKI病史的儿童与无AKI儿童的生长情况。我们假设与无AKI的儿童相比,有AKI的儿童生长情况更差。
对现有的AKI儿童前瞻性和回顾性队列进行便利抽样,这些队列在AKI发作前后已经收集或能够收集生长参数数据。
已发表的关于AKI儿童生长的文献中研究少于5项。我们联系了这些研究的研究者,并通过联系能够收集生长参数数据的儿童AKI研究的主要研究者,增加了其他研究。
来自现有队列中在儿童期评估AKI(暴露因素)的儿童。每个纳入的队列此前均已按照机构指南获得当地机构审查委员会(IRB)的批准。由于我们的研究是一项荟萃分析,且仅使用队列水平的数据,因此本报告无需IRB批准。
使用荟萃均值分析比较AKI发作前后的生长参数(身长和体重Z评分)。采用MOOSE指南。数据使用随机效应模型进行汇总。计算Hedges g,并使用Higgins I统计量来定义队列间异质性导致的变异性。
我们纳入了来自17个现有AKI队列的3586名儿童,这些队列涵盖不同人群,包括婴儿、患有心脏病的儿童、实体器官移植受者以及无心脏病并在AKI后随访12个月至11年的危重症儿童。在最远的随访期,有AKI的儿童身长Z评分低于无AKI的儿童(平均差值 -0.37 [95%置信区间 -0.52, -0.22, p < 0.001]),体重Z评分也更低(平均差值 -0.29 [95%置信区间 -0.43, -0.15, p < 0.001])。这种差异在婴儿中最为显著,因为与无AKI的婴儿相比,有AKI的婴儿在AKI后生长受损(身长Z评分和体重Z评分均如此)。
分析仅纳入了儿童观察性队列的便利样本,研究选择可能存在偏倚,并且我们没有评估这些队列中AKI后肾功能下降(如慢性肾脏病)与生长不良之间的关系。
这项荟萃分析发现,有AKI的儿童在AKI后生长受损。这些发现在婴儿中最为显著。我们建议在临床护理和研究AKI影响的研究中都关注生长结局。
无。